SBC Medical Group (SBCWW) Financials: Revenue & Earnings
$48.33M
Market Cap
—
P/E
—
Forward P/E
—
Score
SBCWW price $0.47 +0.03 +6.80%
SBCWW fair value $17.23. Price $0.47. Price is 97% below fair value.
Below fair value, but more expensive than usual. A smaller discount than on 87% of days in the past 5 years.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Calculated with a 10-year free-cash-flow discount. Starting free cash flow 75.34M. Growth 10.01%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 8.70% (beta 0.8). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 102.85M. Net debt -112.14M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the stock's own 10-year median P/E, kept between 8 and 40. Fewer than five years of history uses the sector's typical P/E. Fair value is the average of the cash-flow value and the earnings value when both exist. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.
Model uncertainty high for this stock
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-11-13 | — | 0.12 | — | 48.90M |
| 2026-08-13 | 0.10 | 0.12 | 49.19M | 45.37M |
| 2026-05-14 | 0.11 | 0.10 | 43.06M | 41.66M |
| 2026-03-27 | 0.14 | 0.12 | 39.57M | 45.44M |
| 2025-11-14 | 0.12 | 0.11 | 43.35M | 45.18M |
| 2025-08-13 | 0.02 | 0.14 | 43.36M | 44.71M |
| 2025-05-15 | 0.21 | 0.15 | 47.33M | 57.55M |
| 2025-03-28 | 0.06 | 0.17 | 44.00M | 56.85M |
| 2024-11-13 | 0.03 | 2.36 | 53.08M | 54.70M |
| 2024-08-16 | 0.20 | 2.36 | 53.00M | 54.70M |
Yield 0.00%. Payout ratio 0.00%. Frequency —.
Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| No data yet. | |||||
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| No data yet. | ||||
SBC Medical Group Holdings Incorporated (SBCWW) trades at $0.47, with a market cap of $48.33M and a trailing P/E of n/a. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
Insights · Dividends · Forecast · Financials · Learn
$48.33M
Market Cap
—
P/E
—
Forward P/E
—
Score